EP4146277A1 - Avian Antibodies Reduce Viral Disease Transmission

EPO published European Patent Application EP4146277A1 for Camas Incorporated, titled 'Reduction of Viral Disease Transmission by Avian Antibodies.' The patent covers compositions containing avian-derived antibodies and methods for their use in reducing transmission of viral diseases. Nine inventors are named including Simplot, Mitteness, Hawkins, Hull, Robley, Larson, Brielmaier, Willaert, and Harkins. The patent is designated in 31 European contracting states.

For intellectual property owners, technology companies, and research institutions, this patent establishes enforceable IP rights in the EU for avian antibody-based antiviral technologies. Entities developing competing avian antibody therapies or related viral transmission reduction methods should conduct freedom-to-operate analyses in the designated states to assess potential infringement risks. The patent's broad designation across major European markets may affect R&D collaboration and licensing strategies in this technology space.